Boston Scientific Corp (BSX) - Medical Equipment - Deals and Alliances Profile

Date: April 20, 2017
Pages: 142
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BE58B1BEEC3EN
Leaflet:

Download PDF Leaflet

Summary

Boston Scientific Corp (Boston Scientific) is a medical device company. It develops, manufactures and markets devices used in a range of interventional medical procedures. The company offers products in seven dedicated business groups, namely, Interventional Cardiology, Cardiac Rhythm Management (CRM), Peripheral Interventions, Electrophysiology, Endoscopy, Urology/Women's Health and Neuromodulation. The company markets its products to hospitals, clinics, outpatient facilities and medical offices worldwide. It has several manufacturing, distribution and technology centers across the world. The company sells its products through direct sales organizations, distributors and dealers in Europe, the Middle East, Africa, Asia-Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp (BSX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Boston Scientific Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment Deals By Type, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deal Details
Asset Purchase
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million
Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access
Boston Scientific Acquires LumenR Tissue Retractor System from LumenR
Boston Scientific Acquires Interventional Radiology Business Of CeloNova Biosciences
Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million
Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies
Venture Financing
NeuroTronik Raises USD23 Million in Series B Financing
SetPoint Medical Raises Funds through Venture Financing
Securus Medical Raises USD10 Million in Series C Financing
NxThera Raises USD40 Million Financing
TVA Medical Raises USD15 Million in Series C Financing
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing
Channel Medsystems Raises USD22 Million in Series C Financing Round
InterVene Raises USD5.9 Million in Series A Financing
EndoChoice Raises USD57 Million in Venture Financing
Amaranth Medical Raises Funds Through Venture Financing
Xlumena Raises US$25 Million In Series C Financing Round
Sensible Medical Raises US$20 Million In Venture Financing
Xlumena Raises US$6 Million In Venture Financing
Setpoint Medical Raises US$27 Million In Venture Financing
Channel Medsystems Raises US$9.7 Million In Series B Financing
Baronova Raises US$27.3 Million In Series C Financing
EndoChoice Raises US$43 Million In Venture Financing
Xlumena Raises US$6 Million In Venture Financing
Neuros Medical Raises US$3.5 Million In Second Round Of Financing
Xlumena Secures US$7 Million In Series B Financing
EndoChoice Secures US$4.6 Million In Series C Financing
Partnerships
BridgePoint Medical Enters Into Licensing Agreement With Covidien
Boston Scientific Partners with Mayo Clinic
Boston Scientific Enters into Sales Cooperation Agreement with Preventice
Boston Scientific Enters into Agreement with Brainlab
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB
Boston Scientific Enters into Co-Development Agreement with Asahi Intecc
Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices
Boston Scientific Enters Into Agreement With Philips Healthcare
Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System
Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers
BG Medicine Enters Into Research Collaboration With Boston Scientific
Boston Scientific Enters Into Partnership With Greatbatch Medical
Lumenis Enters Into Co-Marketing Agreement With Boston Scientific
Boston Scientific Enters Into An Agreement With Fukuda Denshi
Merger
EndoChoice And Peer Medical To Merge
Equity Offering
Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares
VENITI Raises USD25 Million in Series D Equity Financing
MValve Technologies Raises Additional Funds through Private Placement of Shares
Preventice Raises Funds through Private Placement of Shares
EndoChoice Raises USD106 Million in IPO
Iowa Approach Raises Funds through Private Placement of Shares
Debt Offering
Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025
Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020
Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022
Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million
Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million
Asset Transactions
Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To US$5 Million
Boston Scientific Sells Neurovascular Business Unit To Stryker
Acquisition
Boston Scientific to Acquire Symetis for USD435 Million
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million
Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer
Boston Scientific Acquires Cosman Medical
Boston Scientific Acquires 25% Stake in Frankenman Medical
Boston Scientific Acquires Xlumena for USD75 Million
Boston Scientific Enters into Option Agreement to Acquire MValve Technologies
Boston Scientific Acquires Remaining 72% Stake in IoGyn
Vanguard Acquires 6.7% Stake In Boston Scientific
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company
EndoChoice Acquires RMS Endoskopie, Endoscopy Device Maker
Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to US$425 Million
Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker
Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million
Boston Scientific Completes Acquisition Of Cameron Health For Up To US$1.3 Billion
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million
Boston Scientific Completes Acquisition Of Atritech
Boston Scientific Acquires ReVascular Therapeutics
Boston Scientific Acquires Remaining Stake In Intelect Medical For US$60 Million
Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical
Boston Scientific Corp - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Jan 28, 2016: Boston Scientific and Accenture Develop Data-Driven Digital Health Solution to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions
Financial Announcements
Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016
Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015
Corporate Communications
Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors
Legal and Regulatory
Apr 01, 2016: Boston Scientific Statement on Attorney’s Petition to FDA Regarding Mesh Products
Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence
Jan 20, 2016: Boston Scientific Sued Again, This Time for Allegedly Smuggling Cheap Mesh Materials from Counterfeiter in China
Government and Public Interest
Mar 16, 2017: NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife Battery Technology For Treatment Of Heart Failure
Product News
Feb 06, 2017: Boston scientific launches Resonate family of CRT-D devices in Europe
Aug 30, 2016: First randomized trial compares stenting techniques for coronary bifurcation
May 13, 2016: Boston Scientific Announces Schedule of Presentations at EuroPCR 2016
Mar 24, 2016: Boston Scientific Announces Scheduled Presentations at American College of Cardiology's 65th Annual Scientific Session
03/22/2016: Boston Scientific Launches the AXIOS Stent and Electrocautery Enhanced Delivery System
03/10/2016: Boston Scientific Receives U.S. FDA Approval For Blazer Open-Irrigated Catheter
02/23/2016: Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
02/23/2016: UCHealth is Colorado’s first health system to implant new device to prevent strokes
02/22/2016: Boston Scientific Receives CE Mark For Eluvia Drug-Eluting Vascular Stent And Announces Initiation Of New Clinical Trial
02/09/2016: Wake Forest Baptist Offering New Option for Atrial Fibrillation Patients
02/08/2016: Boston Scientific Announces Medicare Will Cover WATCHMAN Left Atrial Appendage Closure Device
02/01/2016: Tufts Health Plan Provides Coverage for First Device-Based Procedure to Treat Severe Asthma
01/11/2016: MedStar Heart & Vascular Institute First in State to Implant WATCHMAN Device
Product Approvals
Mar 10, 2016: Boston Scientific Receives U.S. FDA Approval For Blazer Open-Irrigated Catheter
Feb 23, 2016: Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
Feb 22, 2016: Boston Scientific Receives CE Mark For Eluvia Drug-Eluting Vascular Stent And Announces Initiation Of New Clinical Trial
Other Significant Developments
Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Boston Scientific Corp, Medical Equipment, Key Facts, 2016
Boston Scientific Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment Deals By Type, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Boston Scientific Corp, Deals By Market, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million
Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access
Boston Scientific Acquires LumenR Tissue Retractor System from LumenR
Boston Scientific Acquires Interventional Radiology Business Of CeloNova Biosciences
Boston Scientific Acquires Men's Health and Prostate Health Businesses from American Medical Systems for USD1.65 Billion
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD415 Million
Boston Scientific Acquires fiXate Tissue Band From Anulex Technologies
NeuroTronik Raises USD23 Million in Series B Financing
SetPoint Medical Raises Funds through Venture Financing
Securus Medical Raises USD10 Million in Series C Financing
NxThera Raises USD40 Million Financing
TVA Medical Raises USD15 Million in Series C Financing
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing
Channel Medsystems Raises USD22 Million in Series C Financing Round
InterVene Raises USD5.9 Million in Series A Financing
EndoChoice Raises USD57 Million in Venture Financing
Amaranth Medical Raises Funds Through Venture Financing
Xlumena Raises US$25 Million In Series C Financing Round
Sensible Medical Raises US$20 Million In Venture Financing
Xlumena Raises US$6 Million In Venture Financing
Setpoint Medical Raises US$27 Million In Venture Financing
Channel Medsystems Raises US$9.7 Million In Series B Financing
Baronova Raises US$27.3 Million In Series C Financing
EndoChoice Raises US$43 Million In Venture Financing
Xlumena Raises US$6 Million In Venture Financing
Neuros Medical Raises US$3.5 Million In Second Round Of Financing
Xlumena Secures US$7 Million In Series B Financing
EndoChoice Secures US$4.6 Million In Series C Financing
BridgePoint Medical Enters Into Licensing Agreement With Covidien
Boston Scientific Partners with Mayo Clinic
Boston Scientific Enters into Sales Cooperation Agreement with Preventice
Boston Scientific Enters into Agreement with Brainlab
Boston Scientific Enters into Distribution Agreement with C. R. Bard for Lutonix DCB
Boston Scientific Enters into Co-Development Agreement with Asahi Intecc
Boston Scientific Enters Into Distribution Agreement With Fukuda Denshi For Neuromodulation Devices
Boston Scientific Enters Into Agreement With Philips Healthcare
Vodafone Group Enters Into Co-Development Agreement With Boston Scientific For Health Monitoring System
Boston Scientific Extends Co-Marketing Agreement With Lumenis For Holmium Laser Fibers
BG Medicine Enters Into Research Collaboration With Boston Scientific
Boston Scientific Enters Into Partnership With Greatbatch Medical
Lumenis Enters Into Co-Marketing Agreement With Boston Scientific
Boston Scientific Enters Into An Agreement With Fukuda Denshi
EndoChoice And Peer Medical To Merge
Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares
VENITI Raises USD25 Million in Series D Equity Financing
MValve Technologies Raises Additional Funds through Private Placement of Shares
Preventice Raises Funds through Private Placement of Shares
EndoChoice Raises USD106 Million in IPO
Iowa Approach Raises Funds through Private Placement of Shares
Boston Scientific Raises USD750 Million in Public Offering of 3.850% Notes Due 2025
Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020
Boston Scientific Raises USD500 Million in Public Offering of 3.375% Notes Due 2022
Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million
Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million
Medifocus Completes Acquisition Of Prolieve Business From Boston Scientific For Up To US$5 Million
Boston Scientific Sells Neurovascular Business Unit To Stryker
Boston Scientific to Acquire Symetis for USD435 Million
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million
Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer
Boston Scientific Acquires Cosman Medical
Boston Scientific Acquires 25% Stake in Frankenman Medical
Boston Scientific Acquires Xlumena for USD75 Million
Boston Scientific Enters into Option Agreement to Acquire MValve Technologies
Boston Scientific Acquires Remaining 72% Stake in IoGyn
Vanguard Acquires 6.7% Stake In Boston Scientific
Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million
Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company
EndoChoice Acquires RMS Endoskopie, Endoscopy Device Maker
Boston Scientific Completes Acquisition Of Vessix Vascular, Developer Of Catheter-Based Renal Denervation System, For Up to US$425 Million
Boston Scientific Completes Acquisition Of BridgePoint Medical, Cardiovascular Device Maker
Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million
Boston Scientific Completes Acquisition Of Cameron Health For Up To US$1.3 Billion
Covidien Completes Acquisition Of superDimension, Pulmonary Device Maker, For US$300 Million
Boston Scientific Completes Acquisition Of Atritech
Boston Scientific Acquires ReVascular Therapeutics
Boston Scientific Acquires Remaining Stake In Intelect Medical For US$60 Million
Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical
Boston Scientific Corp, Key Competitors
Boston Scientific Corp, Key Employees
Boston Scientific Corp, Other Locations
Boston Scientific Corp, Subsidiaries

LIST OF FIGURES

Boston Scientific Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Boston Scientific Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

Boston Scientific Corp (BSX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: